InvestorsHub Logo
Followers 45
Posts 5095
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Monday, 12/03/2018 1:52:14 PM

Monday, December 03, 2018 1:52:14 PM

Post# of 15799
“GlaxoSmithKline to Acquire Tesaro for $4.16 Billion -- Update”

I wonder how this affects Opk’s royalty stream from their licensing agreement with Tesaro? Obviously any shares of TSRO they held are good after the buyout but my guess is the longer outlook by Frost was for the cashflow being added to Opk’s bottom line. Anyone know how this plays?

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News